STOCK TITAN

cbdMD, Inc. To Host Conference Call to Discuss September 30, 2024 Fourth Quarter and Fiscal Year 2024 Results

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

cbdMD (NYSE American: YCBD) has scheduled a conference call to discuss its fourth quarter and fiscal year 2024 financial results and business progress. The call will take place on Tuesday, December 17, 2024, at 4:20 p.m. Eastern Time. Investors can access the call through USA/Canada (844-763-8274) or International (647-484-8814) numbers. A replay will be available with passcode 4840580, and a webcast replay will be accessible through January 17, 2026.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction

-2.74%
1 alert
-2.74% News Effect

On the day this news was published, YCBD declined 2.74%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Charlotte, North Carolina--(Newsfile Corp. - December 12, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA) one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Tuesday, December 17, 2024, to discuss the company's September 30, 2024 fourth quarter and fiscal year 2024 financial results and business progress.

CONFERENCE CALL DETAILS

Tuesday, December 17, 2024, 4:20 p.m. Eastern Time
USA/Canada:844-763-8274
International:647-484-8814
Teleconference Replay dial in:
USA/Canada:855-669-9658
International:412-317-0088
Replay Passcode:4840580
Webcast/Webcast Replay link - available through January 17, 2026:
https://www.gowebcasting.com/13876

 

About cbdMD, Inc.

cbdMD, Inc. is one of the leading and most highly trusted and recognized hemp-derived cannabidiol (CBD) brands with a comprehensive line of U.S. produced, THC-free1 CBD products as well as Full Spectrum and Delta 9 THC products. The cbdMD brand currently includes high-quality, premium CBD products including tinctures, gummies, topicals, capsules, sleep aids and more. The Company's Paw CBD brand includes formulated pet products including tinctures, chews and topicals in varying strengths. cbdMD also operates ATRx Labs, a line of functional mushroom supplements. To learn more about cbdMD and the complete line of products, please visit www.cbdmd.com, follow cbdMD on Instagram and Facebook or visit one of the thousands of retail outlets that carry cbdMD products.

1 THC-free is defined as below the level of detection using validated scientific analytical tools.

Contact Information:

cbdMD, Inc.
Ronan Kennedy, CEO
Phone: +1 (704) 445-3064 email: IR@cbdmd.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/233526

FAQ

When will YCBD report its Q4 and FY 2024 earnings?

cbdMD (YCBD) will report its Q4 and fiscal year 2024 earnings on Tuesday, December 17, 2024, at 4:20 p.m. Eastern Time.

How can investors access YCBD's Q4 2024 earnings call?

Investors can access the call via USA/Canada (844-763-8274) or International (647-484-8814) numbers, or through the webcast link available on the company's website.

How long will YCBD's Q4 2024 earnings call replay be available?

The webcast replay will be available through January 17, 2026, and a teleconference replay can be accessed using passcode 4840580.

What is the passcode for YCBD's Q4 2024 earnings call replay?

The replay passcode for cbdMD's Q4 2024 earnings call is 4840580.
Cbdmd Inc

NYSE:YCBD

YCBD Rankings

YCBD Latest News

YCBD Latest SEC Filings

YCBD Stock Data

8.09M
8.76M
16.09%
5.44%
0.97%
Drug Manufacturers - Specialty & Generic
Perfumes, Cosmetics & Other Toilet Preparations
Link
United States
CHARLOTTE